fda compounding glp-1 enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA to Restrict Ingredients Used

Bhardwaj, A., Hollenbeak, C

demonstrated in vitro the anti-leukemic activity of the novel CPT1A reversible inhibitor ST1326 on leukemia cell lines and primary cells obtained from patients with hematologic malignancies, which induces cell growth arrest, mitochondrial damage, and apoptosis 32

That said, whether you're a gym enthusiast aiming to build more muscle or someone simply looking to age more gracefully, carnosine and carnitine could be the game changers you're looking for

Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis

When I look at photos from that time, I see a perfectly normal kid, yet I was treated differently

Drawing on sports nutrition science and customer feedback, the team created formulations that deliver effective doses in convenient formats